ConductScience.org, home

Gene · 708

C1QBP: complement C1q binding protein

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. C1QBP: complement C1q binding protein. Genes, record 708. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/708

On this page

Gene

Symbol
C1QBP
HGNC
Name
complement C1q binding protein
HGNC
NCBI Gene ID
708
NCBI Gene
HGNC ID
HGNC:1243
HGNC
Ensembl
ENSG00000108561
NCBI Gene
Aliases
COXPD33, GC1QBP, HABP1, SF2AP32, SF2p32, gC1Q-R, gC1qR, p32
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q07021Complement component 1 Q subcomponent-binding protein, mitochondrial2824Ensembl, GeneID, HGNC

Source UniProt

Patents82

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1441961Q07021Espacenet
EP 4650780 A22025-11-19638Q07021Espacenet
WO 2025235563 A12025-11-1324Q07021Espacenet
JP 2025517970 A2025-06-12638Q07021Espacenet
WO 2024240908 A12024-11-2812Q07021Espacenet
JP 2023123507 A2023-09-05318Q07021Espacenet
US 11512110 B22022-11-2919Q07021Espacenet
JP 2022546431 A2022-11-0477Q07021Espacenet
US 11446398 B22022-09-2019314Q07021Espacenet
JP 2022524081 A2022-04-27122285Q07021Espacenet

1 to 10 of 82

See all 82 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,264

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleC1QBP papersNewest fiscal year
P30CA008748Cancer Center Support Grant162025
P30CA030199Cancer Center Support Grant (CCSG)72025
ZIAHL006223The role of the intracellular complement system - the complosome - in Th1 biology52025
P01CA092584Structural Cell Biology of DNA Repair Machines42025
P30CA016672Cancer Center Support Grant42025
T32AI007046Infectious Diseases Training Program42025
P01CA013106Targeting Transcription and Splicing in Cancer32025
P30CA014051Cancer Center Support (Core) Grant32025
P30CA033572Cancer Center Support Grant32025
P01AI063302The intersection of innate and adaptive immunity to intracellular pathogens22025

1 to 10 of 1,264Source NIH's project files

See all 1,264 nih grants

Papers2,456

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Proteins from platelet-enriched preparations as candidate biomarkers for major depressive disorder: An exploratory proteomic study.J Affect Disord202742826767PubTator, text miningPubMed
Complement C1q-binding protein at the host-protozoan interface: knowns and unknowns.Trends Parasitol202642481243PubTator, text miningPubMed
1D-2D hybrid based electrochemical sensor for nano-architected sensing of ASFV p32 - an early phosphoprotein.Biosens Bioelectron202642425003PubTator, text miningPubMed
Inhibition of Pax6 sumoylation suppresses the tumorigenicity of pancreatic cancer cells.Cell Death Differ202642342900PubTator, text miningPubMed
CHCHD2 and CHCHD10 promoted autophagic clearance of protein aggregates via GABARAPs.Autophagy202642183628PubTator, text miningPubMed
Unveiling C1QBP: A New Guardian of Dopaminergic Neuron in Parkinson's disease by targeting ULK1 to promote mitophagy and maintain mitochondrial function.Free Radic Biol Med202642176906PubTator, text miningPubMed
Enhancing immune-mediated cancer cell engulfment through biophysical techniques: an in-silico investigation focusing on the peptide-mediated disruption of a C1q-gC1qR(p33) interaction.J Biomol Struct Dyn202642117492PubTator, text miningPubMed
Polysaccharide-Rich Herbal Formula Attenuates Skin Aging and Oxidative Stress in VCD-Induced Menopause Models via Regulation of AQP-3, C1QBP, and K19.Rejuvenation Res202641958012PubTator, text miningPubMed
Spatial multiomics profiling reveals ZFP36-mediated immunometabolic reprogramming in bladder cancer.Proc Natl Acad Sci U S A202641950100PubTator, text miningPubMed
Unveiling the mysteries of C1QBP in gynecological tumors (Review).Mol Clin Oncol202641929232PubTator, text miningPubMed

1 to 10 of 2,456

See all 2,456 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/708

GET https://conductscience.org/api/genes/v1/708/patents?page=2